NKT cell therapy
NKT cell-targeted therapy for cancer
This treatment involves administering dendritic cells isolated from the patient's own blood via intravenous infusion, which are given the ability to activate NKT cells. NKT cells are a type of lymphocyte that not only attack cancer cells directly, but also play a role in regulating the immune response to cancer. The administered dendritic cells are expected to activate NKT cells in the body, which will then act directly and indirectly on cancer to exert an anti-tumor effect.
Blood collection
Immune cell isolation
Administration
Treatment overview
This treatment is an elective medical treatment.
NKT cell therapy flow
1. Extraction of raw materials
To obtain the blood cells necessary for NKT cell cultivation, blood is drawn or apheresis (blood component collection) is performed depending on the patient's condition.
2. Cell Preparation
The blood is sent to the cell culture and processing facility of Medinet Co., Ltd., a manufacturer of specific cell processed products, where it is cultured for approximately three weeks to adjust the NKT cells.
3. Administration
The dendritic cells are sent to a medical institution under appropriate temperature control on the day of treatment and administered intravenously into the bloodstream.
Treatment period and number of times
The treatment will vary depending on the patient's condition and symptoms, so we will make a decision after the patient has undergone an examination and tests.
Cost (free medical treatment)
4,070,000 to 8,140,000 yen/course (4 sessions)
Risks and side effects
After administering the therapeutic cells, you may experience a slight fever (in most cases, the fever will subside within a day and remain below 38°C). Other side effects that are thought to be directly caused by this treatment include fatigue, itching, injection site reactions (such as erythema), and symptoms that appear to be allergic reactions, but in most cases these are mild and disappear within a few days.
About effectiveness
It is hoped that improving immune function, which has been weakened by aging, stress, and the progression of disease, can treat or prevent cancer, but any treatment has limitations in its effectiveness, and results vary from person to person.
Regenerative medicine can only be provided by licensed doctors at facilities whose notification to the Ministry of Health, Labor and Welfare has been accepted. Our hospital is a medical facility that has submitted a Type 3 regenerative medicine provision plan and obtained a plan number in accordance with the Regenerative Medicine Act (Act on the Safety of Regenerative Medicine, etc.).